Hypothalamic volume and cell-type changes in ageing and Alzheimer’s disease

. These fundamental processes are regulated by the hypothalamus, yet how its functionally distinct subregions and cell types change during human ageing and Alzheimer's disease (AD) remains largely unexplored. Here we present HypoAD, an atlas of the human hypothalamus in ageing and AD, including high-resolution magnetic resonance imaging from 458 individuals and single-nucleus RNA sequencing of 614,403 nuclei from young participants, patients with AD and age-matched non-dementia control participants. We show that hypothalamic subregions governing metabolism, stress and circadian rhythms are particularly vulnerable, showing notable changes in both volumes and gene expression during ageing and AD. At the molecular level, machine learning models identified the inflammatory response and regulators of circadian rhythms as key cellular predictors of AD. These signatures were reflected in specific cell types: microglia transitioned to a pro-inflammatory state, whereas inhibitory neurons within sleep-regulating and circadian-regulating hypothalamic subregions showed the most profound transcriptional alterations, including disruptions in ligand-receptor interactions and G-protein-coupled receptor signalling. HypoAD provides a high-resolution volumetric map and a transcriptomic atlas of the human hypothalamus in ageing and AD, relating lifestyle and behavioural changes to the relevant volumetric and molecular pathways. In addition, HypoAD provides a framework to investigate hypothalamic dysfunction and establishes a roadmap for targeted interventions aimed at mitigating physiological disruptions to potentially slow disease progression.

Authors

Institutions

Publication Details

Journal
Nature
Published
2026-11-18
DOI
https://doi.org/10.1038/s41586-026-11305-w
Primary Topic
Single-cell and spatial transcriptomics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hypothalamic volume and cell-type changes in ageing and Alzheimer’s disease

Manu S. Goyal, Jürgen Germann, Kaitlyn H. Hajdarovic, Andrei G. Vlassenko et al.
1 links
Nature
Single-cell and spatial transcriptomics
article

Hypothalamic volume and cell-type changes in ageing and Alzheimer’s disease

Manu S. Goyal, Jürgen Germann, Kaitlyn H. Hajdarovic, Andrei G. Vlassenko, Michael J. MacCoss, Miranda E. Orr, Doudou Yu, William Stafford Noble, Habil Zare, Alexander C. Jackson, Ashley E. Webb, Kelsey R. Babcock, Ghulam Murtaza, Shiva Kazempour Dehkordi, Ivana Delalle, Ritambhara Singh
article en

Abstract

. These fundamental processes are regulated by the hypothalamus, yet how its functionally distinct subregions and cell types change during human ageing and Alzheimer's disease (AD) remains largely unexplored. Here we present HypoAD, an atlas of the human hypothalamus in ageing and AD, including high-resolution magnetic resonance imaging from 458 individuals and single-nucleus RNA sequencing of 614,403 nuclei from young participants, patients with AD and age-matched non-dementia control participants. We show that hypothalamic subregions governing metabolism, stress and circadian rhythms are particularly vulnerable, showing notable changes in both volumes and gene expression during ageing and AD. At the molecular level, machine learning models identified the inflammatory response and regulators of circadian rhythms as key cellular predictors of AD. These signatures were reflected in specific cell types: microglia transitioned to a pro-inflammatory state, whereas inhibitory neurons within sleep-regulating and circadian-regulating hypothalamic subregions showed the most profound transcriptional alterations, including disruptions in ligand-receptor interactions and G-protein-coupled receptor signalling. HypoAD provides a high-resolution volumetric map and a transcriptomic atlas of the human hypothalamus in ageing and AD, relating lifestyle and behavioural changes to the relevant volumetric and molecular pathways. In addition, HypoAD provides a framework to investigate hypothalamic dysfunction and establishes a roadmap for targeted interventions aimed at mitigating physiological disruptions to potentially slow disease progression.

Nature
Boston University (US), University Health Network (CA), Buck Institute for Research on Aging (US), University of Connecticut (US), University of Illinois Urbana-Champaign (US), The University of Texas at San Antonio Health Science Center (US), University of Toronto (CA), University of Washington (US), Washington University in St. Louis (US), Brown University (US), St. Louis VA Medical Center (US), Cognitive Neuroimaging Lab (FR), Krembil Research Institute (CA), Connecticut Institute for the Brain and Cognitive Sciences (US)
National Science Foundation, American Federation for Aging Research, Massachusetts General Hospital, Brown University, Cure Alzheimer's Fund, National Institutes of Health, McDonnell Center for Systems Neuroscience, Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis, National Institute on Aging, National Institute of Mental Health
Good health and well-being
Single-cell and spatial transcriptomics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon